Elonga Review: 30 Years of HRV Science in a 3-Minute Morning Measurement

Like our Content? Stay connected via Google

Follow us for the latest health and wellness information.

Updated August 5, 2026

I currently wear an Oura Ring 4, a Whoop and a Hume Band. I have years of HRV data from multiple devices across training cycles, travel weeks, competition prep and high stress periods. When I learned about the new Elonga device, I was interested. The idea of an accurate and reliable HRV reading in three minutes appealed to me. While I enjoy the data from my wearables, I don't always enjoy having to wear devices all the time. Then I read about spectral analysis, and I was especially curious about the Elonga.

Elonga is not another continuous wear fitness tracker. It is a dedicated HRV measurement device backed by over 30 years of research in spectral analysis of heart rate variability, a methodology that captures information about your autonomic nervous system that the RMSSD method used by Oura, Whoop and most consumer wearables cannot provide. You wear it for three minutes each morning, lying down after waking up. That is it. No 24/7 wear. No charging anxiety. No competing with your smartwatch for wrist real estate. If you want to learn more about what HRV is and how it relates to your health, go listen to my interview with Don Moxley.

Elonga launched in the United States on April 20, 2026, shipping directly from New Jersey. This is the first in-depth English-language review of the device. I took my first reading on April 15, 2026 and measured every morning for 30 days, wearing my Oura Ring 4, Whoop and Hume Band the whole time so I could compare what each one told me on the same mornings.

Disclaimer: Links may contain affiliate links, which means we may get paid a commission at no additional cost to you if you purchase through this page. Read our full disclosure here.

Disclaimer: Elonga sent me this device at no cost for an honest, independent review. I was not paid for this review and all opinions are my own. This article contains affiliate links, which means I may earn a commission at no additional cost to you if you purchase through my links. See my full disclosure policy for details.

What Is Elonga and Why Should You Care About Spectral HRV Analysis?

Most consumer wearables measure HRV using a metric called RMSSD, which stands for root mean square of successive differences. It is a time-domain metric that measures the variation between consecutive heartbeats. RMSSD is useful and well-researched, but it primarily reflects parasympathetic (rest and recovery) activity. It tells you part of the story.

Spectral analysis, by contrast, is a frequency-domain method that breaks down the HRV signal into distinct frequency bands. The high-frequency band reflects parasympathetic activity (your recovery system), while the low-frequency band captures a combination of sympathetic and parasympathetic influence (your stress and activation system). This means spectral analysis can independently measure both branches of your autonomic nervous system rather than just one.

The European Society of Cardiology and the North American Society of Pacing and Electrophysiology established spectral analysis as the reference standard for evaluating the autonomic nervous system in their 1996 Task Force guidelines, published in the European Heart Journal and still the most cited standards in HRV research today. Those guidelines specified both time-domain and frequency-domain methods, but noted that spectral analysis provides information about the sympatho-vagal balance that time-domain metrics alone cannot.

This is what makes Elonga different from every other consumer HRV device I have tested. It is the only consumer wearable I am aware of that uses full spectral analysis to evaluate both branches of your autonomic nervous system, then translates that into actionable readiness, stress and recovery scores.

How Elonga Works: 3 Minutes Every Morning

The measurement protocol is simple. After waking up, you strap the Elonga sensor to your forearm and lie still for three minutes. The sensor uses optical photoplethysmography (PPG) to measure the intervals between your heartbeats with a precision of one-thousandth of a second. From that three-minute window, the Elonga algorithm extracts more than 60 HRV parameters using spectral analysis.

The reason for the morning-only, lying-down protocol is scientific standardization. By measuring at the same time each day, in the same position, before coffee, food or activity can influence your readings, Elonga controls for the variables that make continuous all-day HRV data noisy and harder to interpret. This is the same reason your Oura Ring prioritizes overnight HRV data from your deepest sleep stages, when your body is in its most stable physiological state. I go into this in more detail in my Hume Body Pod review. Taking measurements in the same state at a consistent time each day is the best way to get reliable, accurate measurements from any device.

Once the measurement is complete, the app displays your results across several key metrics: readiness (an aggregate score reflecting your overall autonomic state), stress (sympathetic activity), regeneration (parasympathetic recovery, and Štěpán told me in our meeting they are changing the name of this to recovery), functional age (how your HRV compares to population norms for your demographic) and fitness score (how your cardiovascular fitness is trending over time). The app also provides personalized activity recommendations based on your daily measurement and tracks your habits to show you which behaviors are helping and which are hurting your recovery over time.

The Science Behind Elonga: From Lab to Your Nightstand

The backstory here is what separates Elonga from the typical startup-launches-a-wearable narrative. Elonga's co-founder, Dr. Radim Šlachta, is a physiologist who has spent over 30 years researching spectral analysis of heart rate variability. He started collecting spectral HRV data during his doctoral research at Palacký University in the Czech Republic in the early 1990s, when measurements required a full electrocardiograph setup in a laboratory and took 20 minutes per session.

Dr. Šlachta then founded MySASY, a sports diagnostics company that brought spectral HRV analysis to professional athletes across Europe. MySASY has been used by Olympic team members, Premier League footballers, F1 drivers, professional cyclists and elite coaches. Over more than a decade, MySASY collected over 300,000 individual HRV measurements from professional athletes across Europe. That dataset became the training foundation for the machine learning algorithm powering Elonga.

The breakthrough was using those 300,000 real-world measurements to train a model that could deliver the same quality of spectral analysis in three minutes that previously required 15 to 20 minutes. Elonga's algorithm does this by matching the first three minutes of your HRV signal against a large database of similar waveform patterns, predicting the full spectral picture from an abbreviated recording. This is not a shortcut or an approximation in the way that some wearables oversimplify their metrics. It is a compression of a validated methodology using machine learning trained on a decade of real physiological data.

The MySASY methodology has been used as a measurement tool in published research. A 2022 study in Studia Sportiva used mySASY hardware and software to track autonomic nervous system changes in 19 women undergoing 12 weeks of adjuvant chemotherapy. Parasympathetic activity, total power and total autonomic score all dropped significantly over the course of treatment, while sympathetic activity stayed relatively unchanged. It is a small observational study, not a validation of the Elonga sensor, but it shows the methodology is sensitive enough to detect meaningful physiological change in a clinical population.

A December 2025 pilot study from Charles University in Prague, published in the Journal of Applied Bioanalysis, used the Elonga app directly (alongside the mySASY app, which shares the same underlying algorithm) to track HRV-based recovery across menstrual cycle phases in 20 women aged 20 to 43 over two to four cycles. Regeneration scores tended to be highest in the follicular phase and lowest in the luteal phase, but I want to be straight about the size of that effect: the authors describe it as small, and they concluded that cycle phase exerts only a modest influence on HRV-based recovery. Sleep quality showed a stronger association with recovery than cycle phase did. That is a useful finding in its own right, and arguably a more actionable one, but it is not the dramatic cycle-syncing result the marketing around HRV and hormones tends to promise. It is also a pilot study in women younger than most of my readers, so I would not lean on it heavily if you are perimenopausal.

What Elonga Measures vs Other HRV Devices

Here is how Elonga compares to the other devices I currently wear. This is not about declaring a winner. Each device serves a different purpose, and understanding those differences is what helps you decide whether Elonga adds value to your setup or replaces something else entirely.

The most important distinction here is what Elonga measures versus what the others measure. When your Oura or Whoop gives you an HRV number, it is telling you how active your parasympathetic (recovery) system was during sleep. That is valuable information, but it does not tell you what your sympathetic (stress and activation) system was doing independently. Elonga's spectral analysis separates the two branches, which means you get a more complete picture of your autonomic balance.

Think of it this way: RMSSD tells you how well you recovered. Spectral analysis tells you how well you recovered AND how much residual stress your body is carrying. Those are not always the same thing and the gap between them is where overtraining, burnout and missed early-warning signs live.

If you want to go deeper on how each of these devices compares head-to-head, see my Whoop vs Oura comparison and my Hume Band vs Whoop review. My best fitness watches for women guide covers the broader wearable field, and my RingConn vs Oura comparison is the one to read if subscription cost is your deciding factor.

Who Is Elonga Best For?

Elonga is best for certain use cases. Based on what the device offers and how it works, here is who I think will get the most value from it.

You already wear a smartwatch or ring and want deeper ANS data. Elonga is specifically designed to complement, not replace, devices like Oura, Garmin and Apple Watch. If you already track activity and sleep with another device but want a more detailed daily read on your stress and recovery balance, Elonga fills that gap. The three-minute morning measurement does not conflict with 24/7 wearables at all.

Women who train and want cycle-aware recovery data. The Charles University pilot study using Elonga's methodology found measurable differences in recovery scores across cycle phases, though the effect was small and sleep quality mattered more. If you already track your cycle and adjust training around it, Elonga gives you an objective daily measurement of how your autonomic nervous system is responding. Set your expectations to “one more input” rather than “the answer.”

People who do not want to wear a device 24/7. If the idea of wearing a band or ring to bed every night does not appeal to you, Elonga's three-minute morning-only protocol is a different experience entirely. You measure, you put it on your nightstand and you are done until tomorrow. This is the part I like most about it.

Who should probably skip it: If you are primarily looking for workout tracking, step counting or all-day activity data, Elonga is not that. It does not track your workouts. It does not count steps. It tells you how your body is doing internally so you can make better decisions about how to train, but it does not replace a fitness tracker if that's what you're looking for. If you only want one device that does everything, a Garmin or Apple Watch is a better fit. My guide to the best fitness watches for women covers those options.

Pricing and Subscription Model

Elonga uses a subscription model with the hardware included free. Here are the current US pricing options:

• Monthly membership: $9 per month with a 12-month commitment. The Elonga bracelet (valued at $129) is included free.
• Annual membership: $99 per year ($8.25/month equivalent). Bracelet included free.
• Two-year membership: $149 for two years ($6.20/month equivalent). Bracelet included free.

Every plan includes a 30-day money-back guarantee with no questions asked, a 5-year warranty on the bracelet and access to all current and future features in the app. If you cancel your subscription, you keep the bracelet.

For context, Whoop costs $30 per month with the device included and Oura Ring costs $349 upfront plus $5.99 per month. Over five years that works out to roughly $1,800 for Whoop and about $709 for Oura, against $373 for Elonga on the two-year plan renewed. Elonga at $99 per year with the hardware included makes it the most affordable dedicated HRV device in my rotation by a wide margin.

Check current Elonga pricing and membership options here.

Accuracy: How Does Elonga Stack Up?

The Elonga device itself has not been used in published peer-reviewed validation studies comparing its optical sensor accuracy against ECG gold standards. That is worth noting and it is something I hope the company pursues as they grow.

It is worth knowing what the validation literature says about the devices Elonga is competing with, because “validated” is doing a lot of work in wearable marketing. A 2025 study in Physiological Reports compared five wearables against ECG across 536 nights and found HRV error ranging from about 6% for the Oura Ring 4 up to 16% for the Polar Grit X Pro, with Whoop around 8%. So even among the best-studied consumer devices, accuracy varies by a factor of nearly three.

More relevant to my readers: a 2024 study in Sensors assessed Oura-derived nocturnal HRV against ECG in 92 participants under 45 and 22 aged 45 and over. Agreement was strong overall, but more than half of the participants aged 45 and over exceeded 10% median absolute percentage error, against much tighter agreement in the younger group. Almost nobody mentions this when they quote wearable validation numbers. If you are over 45, the published accuracy figures were largely established in people younger than you. That applies to every device in the table above, Elonga included.

What Elonga has instead of sensor validation is methodological lineage. The underlying spectral analysis approach has decades of published research behind it and the algorithm was trained on over 300,000 measurements collected through MySASY. The methodology has appeared in published research across sports science, oncology and women's health, which is more scientific provenance than most consumer wearable companies can claim. That is not the same as the device being validated, and I want to be clear about the difference.

An independent accuracy comparison published by Fitnesator, a Czech health and fitness site, compared Elonga's measurement precision against Garmin, Oura and Whoop and found Elonga's measurements consistent with the other devices. My own side-by-side testing corroborates the directional agreement: on both a high-recovery and a low-recovery day, Elonga's signals aligned with what my Oura and Whoop were showing, while adding stress-versus-recovery granularity they could not.

What I Want to See Improve

No review from me is complete without an honest assessment of what could be better. Based on my research and impressions so far, here are the areas where I think Elonga has room to grow.

App polish and UX. App Store reviews mention occasional sync issues with Apple Health and some friction around adding activities. The app has improved based on recent update notes, but it is newer and less polished than the Oura or Whoop apps, which have had years and hundreds of millions of dollars in development behind them.

Third-party integrations. I would love to see deeper integration with Apple Health, Garmin Connect and Strava. The ability to pull in activity data from your primary fitness tracker and correlate it with Elonga's morning ANS assessment would make the insights far more actionable.

Published device validation. The methodology is validated. The algorithm is trained on a large real-world dataset. But a published study validating the Elonga optical sensor against ECG would strengthen the credibility case considerably, especially for the medical and research communities. Given that the comparison devices now have multi-night ECG validation studies behind them, this is the gap I would most want closed.

My Real-World Testing: Elonga vs My Oura Ring 4, Whoop, and Hume Band

I measured with all four devices every morning for 30 days. Rather than walk you through a month of screenshots, I picked the two mornings that show the difference most clearly: one day when I was well recovered and one when I was not. These are representative of the pattern I saw across the month, not cherry-picked outliers.

Day 1 (Tuesday April 22): A Good Recovery Day

Tuesday morning, all three devices agreed: I was recovered and ready to train hard.

Elonga: Readiness 43 (up 21 from the previous measurement). The app said “Today will be good. Even intense movement will benefit you.” Stress was 4.4, which Elonga flagged as 39% below my average. Regeneration was 3.3, at my usual baseline with room to improve, but up 12% since the last measurement.

Whoop: Recovery 91% (green). Sleep 100%. I slept 7 hours 55 minutes, from 9:35 PM to 6:02 AM.

Oura: Readiness 92, Optimal. “Above and beyond.” Resting heart rate 51 bpm.

Complete alignment across all three devices. This is a day where any one of them would have given me the green light. But even on this good day, Elonga added something the others did not: it told me my stress was specifically low (39% below my average), not just that I was generally recovered. That distinction matters because you can be well-recovered but still carrying elevated stress. On this day, both branches of my autonomic nervous system were in a good place.

Below you can see the Elonga stress and regeneration detail screens for Tuesday. Stress at 4.4 with the “below average” tag and regeneration at 3.3 showing up 12% from the last measurement. This is the kind of dual-branch data that Oura and Whoop do not provide.

Day 2 (Wednesday April 23): Where Elonga Showed Its Value

Wednesday is where things got interesting and where the spectral analysis difference became tangible.

Elonga: Stress spiked to 6.8, which the app flagged as 33% above my average and a 78% increase since the previous measurement. Regeneration dropped to 2.9, down 10% from the day before and 17% below my average. The app's message was direct: “Your stress level is higher than usual. If it is a result of a higher-intensity activity, it is fine. If you have not engaged in any extraordinary activity, look for aspects in your daily life that may be related to increased stress.” It then recommended specific micro-interventions, including alternating short brisk walks with longer slow walks, repeated 3 to 5 times.

Whoop: Recovery crashed to 27% (red). Sleep dropped to 75%.

Oura: Resting heart rate jumped from 51 to 57 bpm. Recovery index flagged “Pay attention.” HRV balance still read “Good” and sleep was “Optimal.”

All three devices caught that something was off. But here is the difference. Whoop showed me a red 27% recovery circle. Oura showed “Pay attention” on the recovery index. Both told me to take it easy, but neither one told me why.

Elonga did. It separately quantified that my stress branch (sympathetic nervous system) had surged 78% while my recovery branch (parasympathetic) had dropped 10%. That is two distinct pieces of information. Am I not recovered because stress is high, or because my body did not regenerate well? On Wednesday it was both, but the stress spike was the dominant factor. Whoop and Oura cannot make that distinction because RMSSD only measures one branch of the autonomic nervous system.

Here is the Elonga regeneration detail for Wednesday. You can see it dropped from 3.3 to 2.9 and the app gave specific recovery suggestions rather than just a color-coded warning.

The 6 bpm resting heart rate jump that Oura detected (51 to 57) corroborates Elonga's stress reading. That kind of overnight shift typically points to a hard training day, poor sleep quality, alcohol or accumulated life stress. Elonga's spectral analysis quantified the specific autonomic branches involved, while Oura and Whoop gave me an aggregate signal that something was wrong.

What 30 Days of Side-by-Side Measurement Showed

Here is the honest headline from 30 mornings, and it is not the one the marketing would lead you to expect: every single day, all four devices pointed the same direction. Thirty out of thirty. Not once did Elonga tell me I was recovered while Oura and Whoop said I was not, or the reverse. The good mornings were good on every device and the rough mornings were rough on every device.

I want to sit with that for a moment, because it is the most useful thing I can tell you about this device and most reviews would bury it.

What it means is that Elonga is not catching something your Oura or Whoop is missing. If you already wear a recovery-focused tracker and you pay attention to it, Elonga is not going to hand you a green light your ring called red, or flag a bad morning your band waved through. On the question of whether to train hard today, the device I already owned would have gotten me to the same answer 30 times out of 30.

What Elonga added was resolution, not a different verdict. On the rough mornings, Oura and Whoop told me something was off. Elonga told me my sympathetic branch had surged while my parasympathetic branch had dipped, and by how much on each. That is the difference between “you are run down” and “you are run down because your stress system is running hot, not because you slept badly.” Same conclusion, more detail underneath it.

Whether that is worth $99 a year comes down to one question, and only you can answer it: does knowing why change what you do? For me it does, because my nervous system regulation is the specific thing I am working on, and “your stress branch is elevated” points me at breathwork, an earlier bedtime and a walk instead of a lift. If you would take the same rest day either way, the extra granularity is interesting rather than actionable and your existing tracker is enough. I would rather tell you that than sell you a second device you do not need.

Two caveats on the 30 days. First, agreement between four consumer devices is not the same as agreement with an ECG. All four could be off in the same direction and I would never know from this comparison, which is why the sensor validation gap in the accuracy section above matters. Second, 30 days covered a fairly ordinary month for me. It did not include a serious illness, a long-haul flight or a hard taper, which are exactly the situations where a more sensitive measurement would have the most to prove. I will report back when it sees one.

I also want to note that the Elonga app's recommendations were noticeably more specific than what I get from Whoop or Oura on a low-recovery day. Instead of a red or yellow warning, it suggested concrete interventions and explained what might be causing the reading. Whoop does this too when you use the AI feature, but Oura doesn't give advice about how to handle a poor recovery day. For someone who wants actionable guidance rather than a score, that makes a real difference.

Bottom Line: Should You Buy an Elonga?

Elonga occupies a unique position in the wearable landscape. It is not trying to be your fitness tracker, your sleep ring or your smartwatch. It is a dedicated autonomic nervous system assessment tool that uses a measurement methodology with 30 years of research behind it, condensed into a three-minute morning ritual. As someone who often says my nervous system regulation needs work, I had high hopes that this device would give me insight on how to work on that.

After 30 mornings measured alongside an Oura Ring 4, a Whoop and a Hume Band, my answer is more specific than a yes or a no. Elonga never disagreed with those devices about whether I was recovered. What it did was explain the reading rather than just deliver it. If you are the kind of person who wants to know which branch of your nervous system is driving a rough morning, and you will do something different depending on the answer, that explanation is worth $99 a year and then some. If you would take the same rest day either way, your existing tracker already told you what you needed and this is a second subscription for information you will not act on.

At $99 per year with the device included, it is the most affordable entry point into serious HRV tracking, and the spectral analysis approach gives you data that Oura, Whoop and Hume Band cannot provide because they use a different measurement methodology. The honest counterweight is that those devices have published ECG validation studies and Elonga's sensor does not yet, so you are buying into a well-established methodology delivered through hardware that has not been independently checked.

If you want a deeper read on your autonomic nervous system without wearing another device 24/7, and you are honest with yourself that you will use the extra detail, Elonga is worth trying. The 30-day money-back guarantee means you can find out at no risk, and based on my month with it, 30 days is enough to know.

Try Elonga with a 30-day money-back guarantee here.

How I Keep This Review Current

I bought or was sent every device in the comparison table above and I wear them myself. This review is based on 30 consecutive mornings of measuring with Elonga while wearing an Oura Ring 4, a Whoop and a Hume Band, so every comparison here is same-person, same-morning data rather than spec sheets set side by side. Where I have not tested something directly, I say so in the text rather than implying hands-on experience I do not have. The accuracy section is the clearest example: I can tell you what my readings did next to three other devices, but I cannot tell you what they did next to an ECG, and no published study can either yet.

I re-check pricing, membership terms and research citations on this review at least twice a year, and sooner if a reader flags something or the company changes its plans. When I update a section I say what changed rather than quietly editing it. Last full review: August 2026.